*The following content is generated by AI and is for reference only.
<h3>Overview</h3>
<p>This compound is a quinazoline-based intermediate for kinase inhibitor synthesis. The molecular formula is <strong>C24H17ClFN3O2</strong>. CAS No. is not publicly indexed in standard databases.</p>
<h3>Application</h3>
<ul>
<li><strong>Pharmaceutical R&D:</strong> Precursor for EGFR or VEGFR tyrosine kinase inhibitors.</li>
<li><strong>Medicinal Chemistry:</strong> Used in fragment-based drug discovery libraries.</li>
<li><strong>Custom Synthesis:</strong> Sourced by contract manufacturing organizations for API development.</li>
</ul>
<h3>Precautions</h3>
<p>Handle under inert atmosphere; store below -20°C. Avoid skin contact and inhalation of dust. Not approved for direct clinical use as an active ingredient.</p>